baber/WOPTO huggingface dataset:
Patent IL-95742-A0 (IL)
Title: Recombinant polypeptides and peptides,nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
IPC: C12P21/02
Filed: 1990-09-19
Abstract: The invention relates to recombinant polypeptides and peptides and particularly to the polypeptide containing in its polypeptidic chain the following amino acid sequence: the one extending from the extremity constituted by nucleotide at position (1) to the extremity constituted by nucleotide at position (194) represented in FIG. 4 a and FIG. 4 b. The polypeptides and peptides of the invention can be used for the diagnostic of tuberculosis, and can also be part of the active principle in the preparation of vaccine against tuberculosis.
Patent IL-97161-A0 (IL)
Title: Thiazine and oxazine derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D265/36
Filed: 1991-02-06
Abstract: Thiazine (or oxazine) derivatives of the formula [I]: <CHEM> wherein R<1> and R<2> are both H or form a naphthalene ring together with the benzene ring; R<3> and R<4> are both H, or one of them is halogen and another is H; X is S or O; R<5> and R<6> are each i) H, ii) lower alkyl, iii) cycloalkyl, iv) substituted phenyl, v) naphthyl, vi) lower alkyl which is substituted by substituted or unsubstituted phenyl, or vii) S-containing heterocyclic group; one of Z<1> and Z<2> is O and another is H2; A is lower alkylene; R<7> and R<8> are each i) H, ii) lower alkyl, iii) lower alkenyl, iv) lower alkynyl, or v) lower alkyl which is substituted by substituted or unsubstituted phenyl, or both form together N-containing heterocyclic group; provided that when both of R<1> and R<2> are H, Z<2> is O and either one of R<5> and R<6> is substituted phenyl, naphthyl or S-containing heterocyclic group, or their salts, which have calcium antagonistic activity within the cerebral tissues and are useful for prophylaxis and treatment of ischemic encephalopathia and/or cerebral neurocyte dyscrasia, and process for preparing said compounds.
Patent SE-9502909-A0 (SE)
Title: Rengöringsmedelskomposition och användning
Inventor: HOOPER DAVID CHARLES
IPC: C11D3/50
Filed: 1995-08-22
Abstract: •• ••• • 0 • • I 140 OLD 114, ••••41141 •• Sammandraq Anvandning av en deodorantdetergentprodukt fOr tvattning av tyg for att fOrlana tyget formaga att undertrycka odor fran manniskokroppen nar tyget bares sasom kladesplagg, varvid detergentprodukten innefattar: fran 5 till 95 vikt-t av en detergentaktiv fdrening av icketvaltyp, vald bland anjoniska, nonjoniska, katjoniska, amfotera och zwitterjoniska detergentaktiva foreningar; fran 0,05 till 3 vikt-% av en deodorantkomposition innefattande en kombination av parfymmaterial, som sanker partialangtrycket av morfolin med minst 10 % mer an vad corn erfordras enligt Raoults lag; och andra detergenttillsatser, vilka innefattar en stod- substans och utgor resten av produkten; varvid detergentprodukten har ett odorreduktionsvarde av minst 0,50 enligt test baserat pa Whitehouse-och-Carter-testet med foljande modifikation: varderingen av kroppsodbren genomfOres 5 timmar efter behandling med anvandning av en odorgraderingsskala frail 0 till 5, varvid testet genomfores efter tillforing till skjorttyg under tvattcykeln vid en tvattprocess och den pa skjorttyget kvarvarande kroppsodoren bedOmes.
Patent FI-20002478-A0 (FI)
Inventor: PEHU EIJA
IPC: C12N15/84
Filed: 2000-11-13
Abstract: The present invention relates to plant biotechnology and specifically to a method for genetically transforming Camelina sativa with Agrobacterium-mediated transformation system. It comprises Camelina sativa for producing homologous and heterologous recombinant products including oil and protein products and assessing and screening the efficacy of plant transformation. Also disclosed are transgenic Camelina sativa plants, seeds as well as cells, cell-lines and tissue of Camelina sativa.
Patent FI-20002564-A0 (FI)
Inventor: LAAMANEN HEIKKI
IPC: H03H19/00
Filed: 2000-11-22
Abstract: The invention relates to a method and system for implementing a digitally controlled sample and timing clock in a system performing analog and digital signal processing. According to the method, as the timing clock of the digital signal processing is used a clock with a controllable frequency such that said digital signal processing can have a function suited for controlling the frequency of said timing clock, and the conversion of the signal is performed in synchronism with the timing clock of the digital signal processing operation when a delta-sigma converter or a switched-capacitor filter device is employed. According to the invention, the timing and sample clocks are generated by dividing a fixed-frequency clock operating at a frequency substantially higher than that of said timing/sample clock by a digital divider of an integer division factor whose division factor is controlled by means of an at least second-order delta-sigma modulator capable of delivering an output signal of two values so that one of the modulator output signal values selects the division factor to be N while the other value selects the division factor to be N+1, and, further, the delta-sigma modulator controlling the integer-factor divider is adapted to be clocked by the timing signal generated by said integer-factor divider.
Patent FI-20030561-A0 (FI)
Inventor: SAVILAHTI HARRI
IPC: C12N15/90
Filed: 2003-04-14
Abstract: The present invention relates to genetic engineering and especially to the use of DNA transposition complex of bacteriophage Mu. In particular, the invention provides a gene transfer system for eukaryotic cells, wherein in vitro assembled Mu transposition complexes are introduced into a target cell and subsequently transposition into a cellular nucleic acid occurs. The invention further provides a kit for producing insertional mutations into the genomes of eukaryotic cells. The kit can be used, e.g., to generate insertional mutant libraries.
Patent IL-111196-A0 (IL)
Title: Peptides and pharmaceutical compositions comprising them
IPC: C12N15/09
Filed: 1994-10-07
Abstract: The present invention relates generally to peptide sequences, and methods of their use, which sequences modulate the activity of anti-idiotypic T cells. The activity of the anti-idiotypic T cells of interest is related to the ability of these T cells to recognize anti-p277 T cells. The peptides of the present invention thus comprise important tools in the effort to diagnose, prevent, alleviate or treat disease related to insulin-dependent diabetes mellitus (IDDM).
Patent IL-117232-A0 (IL)
Title: A process for the production of an ester or polyester of carboxylic acid from a concentrated fermentation liquor
IPC: C07C235/06
Filed: 1996-02-22
Abstract: The invention provides a process for the production of a condensation product selected from the group consisting of an amide and an ester of a carboxylic acid from an organic compound selected from the group consisting of organic compounds carrying a hydroxyl group and organic compounds carrying an amine group and from a concentrated medium resulting from fermentation, said medium containing a salt of said acid, said salt being selected from the group consisting of a sodium salt, a calcium salt and mixtures thereof and said medium being at a pH of at least the pKa of said acid, said process comprising reacting said medium with said organic compound and with CO2, whereby said condensation product and a salt selected from the group consisting of sodium carbonate, sodium bicarbonate, calcium carbonate, calcium bicarbonate and mixtures thereof are formed; and, separating said condensation product from the reaction mixture formed in the previous step.
Patent IL-124537-A0 (IL)
Title: Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
IPC: C07D235/04
Filed: 1996-12-05
Abstract: Compounds of formula (I):    <IMAGE>  (I)  wherein: n, A, R1, R2, R3, and R4 have meanings as defined herein, or a pharmaceutically acceptable salt thereof, are useful as anti-coagulants.
Patent IL-153406-A0 (IL)
Title: Cyclopentanoindoles, compositions containing such compounds and methods of treatment
IPC: A61P11/06
Filed: 2001-07-23
Abstract: Substituted cyclopentanoindole derivatives are antagonists of prostaglandins, and as such are useful for the treatment of prostaglandin mediated diseases.
Patent IL-173058-A0 (IL)
Title: Method for the transmission of digital content via a mobile telephone network
IPC: G06Q30/00
Filed: 2006-01-10
Abstract: The method involves transmitting the digital content to a mobile telephone (20), as well as marking data associated with the digital content, where the marking data includes a link. The marking data are adapted to be recognized by the mobile telephone, so that the mobile telephone transfers only the link associated with the content, when a user (10) of the mobile telephone (20) orders the transfer of content to another mobile telephone (60). Independent claims are also included for the following: (A) a method for transferring a digital content from a mobile telephone to another telephone (B) a server for downloading digital content (C) a mobile telephone capable of downloading a digital content.
Patent IL-176467-A0 (IL)
Title: Edge wheel dry manifold
IPC: H01L21/687
Filed: 2006-06-21
Abstract: A apparatus for drying a substrate includes a vacuum manifold positioned adjacent to an edge wheel. The edge wheel includes an edge wheel groove for receiving a peripheral edge of a substrate, and the edge wheel is capable of rotating the substrate at a desired set velocity. The vacuum manifold includes a proximity end having one or more vacuum ports defined therein. The proximity end is positioned at least partially within the edge wheel groove, and using supplied vacuum removes fluids that accumulate in the edge wheel groove and prevents re-deposit of trapped fluids around the peripheral edge of the substrate.
Patent IL-180332-A0 (IL)
Title: Cannula for in utero surgery
Filed: 2006-12-26
Abstract: A cannula, a straightener, and a cannula and straightener combination for insertion into tissue, the cannula including an elongated rigid hollow tube having a proximal end, a distal end, and a passageway extending therebetween. The distal end includes a memory of directionality to bend about a radius. The cannula straightener straightens the distal end of the cannula when inserted through the passageway of the cannula. The present invention also includes methods of inserting a cannula, removing a cannula, and performing surgery with a cannula in tissue or in fetal tissue. The present invention further includes methods of performing biliary cannulation in a transhepatic approach, performing fetal aortic valvuloplasty, placing catheters into the brachial plexus for pain management, placing catheters into the epidural space for anesthesia, thoracic dissection treatment, laparoscopic dissection, and hydro dissection of tissue.
Patent IL-186675-A0 (IL)
Title: Mac multiplexing and tfc selection procedure for enhanced uplink
IPC: H04W88/08
Filed: 2007-10-16
Abstract: The user equipment produces medium access control-dedicated channel (MAC-d) for transfer of logical channels over an enhanced dedicated physical channel (E-DPCH) and receives power offset, serving grant. The equipment selects enhanced dedicated channel transport formal combination (E-TFC) not exceeding size derived from serving grant and the power offset. The equipment receives selected E-TFC and MAC-d flows and multiplexes data of MAC-d flows into MAC-enhanced dedicated channel packet data unit (MAC-e PDU) with size related to selected E-TFC. Independent claims are included for the following: (1) method for transferring data over enhanced dedicated channel (E-DCH); (2) wide band code division multiple access (W-CDMA) frequency division duplex (FDD) base station; (3) W-CDMA FDD communication system; and (4) method for multiplexing data over E-DCH.
Patent IL-196900-A0 (IL)
Title: Autologous t-cell vaccines compositions
IPC: A61K39/38
Filed: 2009-02-04
Abstract: The present invention relates to improved autologous T cell vaccines and methods for their production. The invention is also directed to methods for treating T cell associated diseases such as multiple sclerosis are rheumatoid arthritis using autologous T cell vaccines.
Patent RO-132186-A0 (RO)
Title: Terrace armchair
Inventor: MURGULEŢ ION
IPC: A47C4/24
Filed: 2017-06-26
Abstract: The invention relates to a quick folding and unfolding armchair used as terrace and garden furniture or for resting and leisure places. According to the invention, the armchair comprises a metal framework formed of a pair of long legs (1) of square pipe, in the shape of an elongate arc of circle, with a frontward concavity, and a pair of short legs (5) made of the same square pipe profile, in the shape of elongate arc of circle, with downward concavity, articulated to one another with some bolts (7), a seat (B) formed of two longitudinal beams (8) and a flat steel bar (9) arranged in the shape of the letter U, on which some wide wooden collar beams (10) are mounted, at the rear side, the longitudinal beams (8) having some ends (b) bent in the shape of a hook, which are fixed on a cross rod (11), welded to the long legs (1) for positioning and setting the seat (B) in the horizontal plane in unfolded position and in the state to be used, the longitudinal beams (8) being also provided with two welded eyes (12) wherethrough a rod (13) fixed in the upper side of the short legs (5) passes, rod (13) in relation to which the seat (B) can rotate for being folded upwards, positioning it in front of a back rest (A), or downwards, positioning behind the back rest (A), on the long legs (1) there being some elbow rests (C and D), each of the two elbow rests (C and D) having the possibility to take a horizontal unfolded position and also a folded position in the plane of the back rest (A), independent from one another and independent from the position of the folded or unfolded seat (A) so that the user has the possibility to rest his elbows on both elbow rests (C and D) or, if needed, to fold one or both elbow rests (C and D) upright.
Patent RO-135150-A0 (RO)
Title: Anaerobic thermophilic biodegradation plant and anaerobic thermophilic biodegradation process
Inventor: MORĂRESCU VALER
IPC: C02F3/28
Filed: 2021-02-17
Abstract: The invention relates to a plant and to a process of anaerobic thermophilic biodegradation in cascade meant to recover the energy potential of biodegradable household waste, wastewater, manure and biodegradable waste from the food industry. According to the invention, the plant consists of stations (1) for supplying waste, manure, wastewater, in connection with a micronizer (2) which grinds and separates light non-biodegradable components (4) and heavy non-biodegradable components (5) from biodegradable components (3) which enter a series of cascade reactors (6) which provide the anaerobic thermophilic biodegradation of the components up to their separation into biogas (9), compost (10) and clean water (11). The claimed process has the following steps: a. introduction of waste, manure, farm waste, food industry waste and wastewater in a feeding station (1), b. micronization of waste from the feeding station (1), in a micronizer (2), for separating waste into light non-biodegradable components (4), heavy non-biodegradable components (5) and biodegradable components (3), c. anaerobic thermophilic biodegradation of biodegradable waste (3) from the micronizer (2), in a series of cascade reactors (6), at temperatures ranging between 30...70°C, pressures between 0,2...0,4 bar, for 5...14 days, with controlled stirring, up to their conversion and separation into biogas (9), compost (10) and clean water (11), the liquid component being taken over from the bottom of each reactor (6) and sent to the top of the next reactor, while the gaseous component is taken over from the top of each reactor and sent to the bottom of the next reactor (6) for the countercurrent flow of the liquid component in relation to the gaseous component, in each reactor.
Patent IE-910858-A1 (IE)
Title: Aggregate for use in making structural elements
IPC: C04B14/12
Filed: 1991-03-14
Abstract: A method of producing a lightweight building material, such as an aggregate, comprises mixing clay powder with a high percentage of coal dust to create areas of coal within the mixture which represent a desired density of voids, pelletising the mixture in the case of aggregate, and firing it to burn off the coal and harden the clay. The burning off of the coal leaves lightweight void areas within the hardened clay to form a lightweight building material or aggregate.
Patent MA-27932-A1 (MA)
Title: Derives du dioxyde de benzoisothiazole/thiazole substitues, procede de production et utilisation desdits derives
Inventor: PETRY STEFAN
IPC: C07D417/12
Filed: 2006-01-26
Abstract: L'invention concerne des composés de formule (I), dans laquelle les radicaux ont la signification indiquée dans la description, ainsi que leurs sels physiologiquement tolérables Ces composés sont appropriés par exemple comme médicaments servant à faire baisser le taux de sucre dans le sang et servant à la prévention et au traitement du diabète.
Patent MA-37544-A1 (MA)
Title: Concept et procede d'execution nouveau pour moteur graphique 3d temp-reel
Inventor: MOUMEN YOUNES
IPC: G06F3/048
Filed: 2014-11-17
Abstract: Nouvelle architecture et procédé d'exécution d’un moteur graphique et physique basé sur un système de communication par messages utilisant l'inversion de contrôle des classes. Il est facile à implémenter avec un langage déclaratif. Son architecture définit des scènes contenant des données partagées et des objets. Des contrôleurs créés par le développeur ou géré par le moteur génèrent des messages qui peuvent être diffusés à tous les objets ou envoyés spécifiquement à des objets. Le développeur définit les interactions en décrivant les scènes, les contrôleurs générateurs de messages et les réponses aux messages.
Patent UY-29421-A1 (UY)
Title: Nuevos compuestos de n-(n-sulfonilaminoarilmetil) ciclopropanocarboxanida sustituidos, comoposiciones farmacéuticas que los contienen a aplicaciones.
Inventor: HANAZAWA TAKESHI
IPC: C07C311/08
Filed: 2006-03-16
Abstract: Compuestos de fórmula (I): sal farmacéuticamente aceptable del mismo, donde A, R1, R2, R3, R4, y R5, son como se describe en la memoria descriptiva y reivindicaciones, composiciones que los contienen y aplicaciones en tratamiento de afección mediada por actividad agonista de 5-HT4 tales como, aunque sin limitación, enfermedad de reflujo gastroesofágeo, enfermedad gastrointestinal, trastorno de motilidad gástrica, dispepsia no ulcerosa, dispepsia funcional, síndrome del intestino irritable (IBS), estrenimiento, dispepsia, esofagitis,enfermedad gastroesofágea, náuseas, enfermedad del sistema nervioso central, enfermedad de Alzheimer, trastorno cognitivo, emesis, migrana, enfermedad neurológica, dolor, trastornos cadiovasculares, insuficiencia cardiaca, arritmia cardiaca, diabetes, síndrome de apnea.
Patent UY-29745-A1 (UY)
Title: Mezclas pesticidas
Inventor: JURGEN DR LANGEWALD
IPC: C07D213/64
Filed: 2006-08-11
Abstract: Mezclas pesticidas que comprenden, como componentes activos, un compuesto de fenilsemicarbazona de la fórmula (i) (el preferido es metaflumizona), en donde R1 y R2 son, de modo independiente entre si, hidrógeno, ciano, halógeno, alquilo C1-C4, alcoxi C1-C4, haloalquilo C1-C4 o haloalcoxi C1-C4 y Rr3 es alcoxi C1-C4, haloalquilo C1-C4 o haloalcoxi C1-C4, o una de sus sales aceptables en agricultura, y un compuesto de la fórmula (ii) - piridalilo (2,6-dicloro-4-(3,3-dicloroaliloxi)fenil-3-(5-(trifluorometil)-2-piridiloxi)propileter - o una de sus sales aceptables en agricultura.
Patent UY-29978-A1 (UY)
Title: Inhalador y almacén para una formulación seca de medicamentos así como procedimiento y aplicación correspondientes
Inventor: GERT-BLANKENSTEIN
IPC: B05B15/00
Filed: 2006-11-29
Abstract: Se proponen un inhalador, un almacén y un procedimiento para la pulverización de una formulación seca de medicamentos. La formulación de medicamentos es disuelta en primer lugar con un disolvente líquido y es pulverizada después junto con el disolvente. Esto hace posible una dosificación sencilla y un buen almacenamiento de la formulación de medicamentos en estado seco. La formulación seca de medicamentos es preparada de manera especialmente preferida por el desecado de una formulación de medicamentos líquida en primer lugar. De manera alternativa también se puede expender la formulación desecada de medicamentos en forma seca con un chorro de gas.
Patent UY-30516-A1 (UY)
Title: Derivados de iminoimidazopiridina que tienen actividad antitrombotica
Inventor: CZECH JOERG
IPC: C07D265/36
Filed: 2007-07-31
Abstract: La invencion se refiere a compuestos de la formula I que tienen actividad antitrombotica, que en particular inhiben el receptor activado por proteasas tipo 1 (PAR1), procedimientos para su preparacion y su uso como medicamentos.
Patent UY-30636-A1 (UY)
Title: Composision farmaceutica de liberacon modificada de un musculo relajante y un aine
Inventor: BARRANCO GUSTAVO
IPC: A61K9/22
Filed: 2007-10-09
Abstract: La presente invencion se refiere a una composicion farmacéutica de liberacion modificada en cápsulas con microesferas recubiertas que comprende la combinacion de dos principios activos de tiempos de concentracion plasmática radicalmente diferentes, éstos son un musculo relajante (tizanidina) y un analgésico antiinflamatorio no esteroide (meloxicam), vehículo o excipientes farmacéuticamente aceptables; así como un proceso para la manufactura de la composicion y al uso de dicha combinacion para la preparacion de un medicamento con actividad terapéutica sinérgica indicada en el tratamiento de espasticidad, desordenes relacionados con padecimientos musculares y/o musculo esquelético y dolor en general de moderado a severo.
Patent UY-31068-A1 (UY)
Title: Ligandos purinoreceptores p2x, metodos para la prparacion de los mismos, composiciones farmaceuticas que los contienen y sus usos 570
Inventor: TOMASZEWSKI MIROSLAU
IPC: A61P29/00
Filed: 2008-05-07
Abstract: Compuestos de Fórmula I o sales farmacéuticamente aceptables de los mismos: donde R11, R2, R3, R4 y R5 son como los definidos en la descripción así como sales y composiciones farmacéuticas que incluyen los compuestos son preparados. Estos son útiles en la terapia, particularmente en el manejo del dolor.
Patent UY-31244-A1 (UY)
Title: Profarmacos dipeptoides y su uso
Inventor: ALBRETCH-KOEPPER DR BARBARA
IPC: A61P9/00
Filed: 2008-07-22
Abstract: La presente solicitud se refiere a derivados profármaco de 2-amino-6-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}tio)-4-[4-(2-hidroxietoxifenil]piridin-3,5-dicarbonitrilo, a procedimiento para su preparacion, a su uso para el tratamiento y/o la profilaxis de enfermedades, así como a su uso para la preparacion de medicamentos para el tratamiento y/o la profilaxis de enfermedades, particularmente de enfermedades cardiovasculares.
Patent DZ-522-A1 (DZ)
Inventor: GEST RENE
IPC: C03B/
Filed: 1983-04-04
Granted: 2004-09-13
Abstract: This invention relates to internal combustion burners. In the burners according to the invention, the combustible mixture flows in counter-current to the combustion gases while in contact with the same, and the introduction of the mixture into the combustion chamber is effected along a wall of said chamber and the emitted gases leave the chamber along a second wall thereof, the two walls being opposite one another. The burners according to the invention, which have improved performance and versatility of use, are of use more particularly for mineral fibre drawing processes.